Phase 2 Graft vs Host Disease Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD
Graft vs Host Disease
Chang Gung Memorial Hospital35 enrolled1 locationNCT07364617
Recruiting
Phase 1Phase 2
Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Graft vs Host Disease
National Cancer Institute (NCI)50 enrolled2 locationsNCT05531786
Recruiting
Phase 2
A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCT
Chronic Graft Versus Host DiseaseGraft vs Host Disease
WeiShi30 enrolled1 locationNCT07606703
Recruiting
Phase 2
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
Graft vs Host Disease
Boston Children's Hospital160 enrolled15 locationsNCT04380740
Recruiting
Phase 2
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
Hematologic MalignancyGraft vs Host DiseaseGraft-Versus-Host Disease
Memorial Sloan Kettering Cancer Center46 enrolled8 locationsNCT07006506
Recruiting
Phase 2
Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
Vitamin A deficiencyGraft vs Host DiseaseVitamin D Deficiency
Children's Hospital Medical Center, Cincinnati190 enrolled3 locationsNCT06450925
Recruiting
Phase 1Phase 2
A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Abatacept for the Prevention of Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Graft vs Host Disease
Northwell Health10 enrolled1 locationNCT06681922